OBJECTIVE: The purpose of this study was to explore the development of a pre-clinical nuclear imaging model as a tool for testing novel radiopharmaceutical agents for imaging and/or delivery systems to human tissues. Here we report for the first time the imaging of human synovial tissue transplanted into SCID mice using a radiolabelled anti-E-selectin antibody and NanoSPECT/CT technology. METHODS: Human synovium was transplanted into SCID mice. Two to three weeks post-transplantation tissue vasculature was stimulated with TNF-alpha by intra-graft injection 5 h prior to intravenous injection of (111)In-labelled anti-E-selectin or isotype control antibody. At 1, 4, 24 and 48 h animals were imaged and transplant activity quantified. RESULTS: Activity was detectable in the grafts at all time points, with clear delineation of the transplants in the reconstructed images. A significant difference in graft radioactivity was observed at 4 and 24 h with a significantly higher uptake (P < 0.05) of (111)In-anti-E-selectin compared with isotype control antibody. CONCLUSIONS: This article highlights NanoSPECT/CT imaging in the SCID mouse chimeric model as a powerful tool for the pre-clinical development of radiopharmaceutical and delivery agents targeting human synovial tissue in vivo.
OBJECTIVE: The purpose of this study was to explore the development of a pre-clinical nuclear imaging model as a tool for testing novel radiopharmaceutical agents for imaging and/or delivery systems to human tissues. Here we report for the first time the imaging of human synovial tissue transplanted into SCIDmice using a radiolabelled anti-E-selectin antibody and NanoSPECT/CT technology. METHODS:Human synovium was transplanted into SCIDmice. Two to three weeks post-transplantation tissue vasculature was stimulated with TNF-alpha by intra-graft injection 5 h prior to intravenous injection of (111)In-labelled anti-E-selectin or isotype control antibody. At 1, 4, 24 and 48 h animals were imaged and transplant activity quantified. RESULTS: Activity was detectable in the grafts at all time points, with clear delineation of the transplants in the reconstructed images. A significant difference in graft radioactivity was observed at 4 and 24 h with a significantly higher uptake (P < 0.05) of (111)In-anti-E-selectin compared with isotype control antibody. CONCLUSIONS: This article highlights NanoSPECT/CT imaging in the SCIDmouse chimeric model as a powerful tool for the pre-clinical development of radiopharmaceutical and delivery agents targeting human synovial tissue in vivo.
Authors: Kristiina Aalto; Anu Autio; Elina A Kiss; Kati Elima; Yvonne Nymalm; Tibor Z Veres; Fumiko Marttila-Ichihara; Heli Elovaara; Tiina Saanijoki; Paul R Crocker; Mikael Maksimow; Eva Bligt; Tiina A Salminen; Marko Salmi; Anne Roivainen; Sirpa Jalkanen Journal: Blood Date: 2011-08-05 Impact factor: 22.113
Authors: Fatemeh Khodadust; Aiarpi Ezdoglian; Maarten M Steinz; Judy R van Beijnum; Gerben J C Zwezerijnen; Gerrit Jansen; Sander W Tas; Conny J van der Laken Journal: Int J Mol Sci Date: 2022-06-25 Impact factor: 6.208
Authors: Eric A Simone; Blaine J Zern; Ann-Marie Chacko; John L Mikitsh; Eric R Blankemeyer; Silvia Muro; Radu V Stan; Vladimir R Muzykantov Journal: Biomaterials Date: 2012-05-04 Impact factor: 12.479
Authors: Sarah E Wythe; Danielle DiCara; Taher E I Taher; Ciara M Finucane; Rita Jones; Michele Bombardieri; Y K Stella Man; Ahuva Nissim; Stephen J Mather; Yuti Chernajovsky; Costantino Pitzalis Journal: Ann Rheum Dis Date: 2012-07-27 Impact factor: 19.103